Education
About Us
Working with TipRanks
Follow Us
Syndax Pharmaceuticals Inc. (SNDX)
:SNDX
Syndax Pharmaceuticals (SNDX) Ownership Overview
1.31% Insiders
18.04% Mutual Funds
50.59% Other Institutional Investors
13.74% ETFs
16.32% Public Companies and
Individual Investors
The ownership structure of Syndax Pharmaceuticals (SNDX) stock is a mix of institutional, retail, and individual investors. Approximately 82.37% of the company’s stock is owned by Institutional Investors, 1.31% is owned by Insiders, and 16.32% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 12, 2025 | Michael Metzger Ceo,director | xxxxxxxxxxxxx | $205964 |
| Feb 12, 2025 | Keith Goldan Cfo | xxxxxxxxxxxxx | $58544 |
| Feb 12, 2025 | Gallagher Neil President, Head Of R&d | xxxxxxxxxxxxx | $71579 |
| Jun 17, 2024 | Keith Goldan Cfo | xxxxxxxxxxxxx | $25025 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $697883 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $25009635 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,534,620 | Institution | 5.27% | 58,723,329 | |
| 3,845,640 | Institution | 4.47% | 49,801,038 | |
| 3,842,430 | Institution | 4.47% | 49,759,469 | |
| 2,987,450 | Institution | 3.47% | 38,687,478 | |
| 2,023,792 | Institution | 2.35% | 26,208,106 | |
| 1,891,803 | Institution | 2.20% | 24,498,849 | |
| 1,178,062 | Institution | 1.37% | 15,255,903 | |
| 1,025,000 | Institution | 1.19% | 13,273,750 | |
| 973,129 | Institution | 1.13% | 12,602,021 | |
| 973,057 | Institution | 1.13% | 12,601,088 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,842,430 | Institution | 4.47% | 49,759,469 | |
| 2,987,450 | Institution | 3.47% | 38,687,478 | |
| 1,178,062 | Institution | 1.37% | 15,255,903 | |
| 973,129 | Institution | 1.13% | 12,602,021 | |
| 922,400 | Institution | 1.07% | 11,945,080 | |
| 903,102 | Institution | 1.05% | 11,695,171 | |
| 866,265 | Institution | 1.01% | 11,218,132 | |
| 590,923 | Institution | 0.69% | 7,652,453 | |
| 508,734 | Institution | 0.59% | 6,588,105 | |
| 472,230 | Institution | 0.55% | 6,115,379 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,552,448 | Institution | 2.97% | 39,920,287 | |
| 2,190,775 | Institution | 2.55% | 28,370,536 | |
| 1,861,073 | Institution | 2.16% | 24,380,056 | |
| 1,292,692 | Institution | 1.50% | 20,217,703 | |
| 719,166 | Institution | 0.84% | 9,313,200 | |
| 496,960 | Institution | 0.58% | 6,435,632 | |
| 402,937 | Institution | 0.47% | 5,278,475 | |
| 375,841 | Institution | 0.44% | 5,878,153 | |
| 244,079 | Institution | 0.28% | 3,817,396 | |
| 147,437 | Institution | 0.17% | 1,931,425 |
FAQ
Who Owns Syndax Pharmaceuticals Inc. (SNDX)?
According to the latest TipRanks data, approximately 50.59% of the company's stock is held by institutional investors, 1.31% is held by insiders, and 16.32% is held by retail investors.
What percentage of Syndax Pharmaceuticals Inc. (SNDX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 50.59% of Syndax Pharmaceuticals Inc. (SNDX) stock is held by institutional investors.
What percentage of Syndax Pharmaceuticals Inc. (SNDX) stock is held by retail investors?
According to the latest TipRanks data, approximately 16.32% of Syndax Pharmaceuticals Inc. (SNDX) stock is held by retail investors.
Who owns the most shares of Syndax Pharmaceuticals Inc. (SNDX)?
Vanguard owns the most shares of Syndax Pharmaceuticals Inc. (SNDX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.